Twitter | Search | |
Ana Vallejo
Periodista especializada en salud. Responsable de comunicación en . Perfil personal
820
Tweets
863
Following
935
Followers
Tweets
Ana Vallejo retweeted
WECAN Nov 29
WECAN has developed guiding principles for reasonable legal agreements between patient advocates and pharmaceutical companies in a project coordinated by in collaboration with and along with 12 pharmaceutical companies
Reply Retweet Like
Ana Vallejo retweeted
Plan Antibióticos Nov 18
Hoy celebramos el Día Europeo para el Uso Prudente de los 💊 Con la ayuda de todos, podemos conseguir que estos medicamentos sigan funcionando. Para luchar frente a la 🦠: ! ⚠️
Reply Retweet Like
Ana Vallejo Nov 18
Reply Retweet Like
Ana Vallejo retweeted
EveryWhereSchools Nov 13
¿Nos ayudas a conseguir que este proyecto se haga realidad? La Educación es una emergencia y este proyecto tiene como objetivo mejorar la educación y sostenibilidad de la escuela Shakinah en Kenia
Reply Retweet Like
Ana Vallejo retweeted
TERESA TERRÉN LALANA Nov 13
Desde estamos realizando un estudio para conocer el grado de conocimiento que los pacientes con tenemos sobre los tratamientos. La encuesta es absolutamente confidencial ¡Contamos contigo! Tú participación es importante. GRACIAS
Reply Retweet Like
Ana Vallejo retweeted
CML AdvocatesNetwork Oct 31
Today at 1PM h CET, our co-founder presents a webinar on : how we strategically developed online/offline tools to boost to become a joint global movement of our member organisations. Follow it on Facebook:
Reply Retweet Like
Ana Vallejo retweeted
MPE Oct 21
The use of the Complementary and Alternative Medicines (CAM) is very frequent. Up to 60-90% of use them but most of them don't talk about it with their oncologists
Reply Retweet Like
Ana Vallejo Oct 21
Es lo que tienen los selfies!!
Reply Retweet Like
Ana Vallejo Oct 21
Seguimos conociendo las novedades en e informando en el booth de sobre las iniciativas que estamos desarrollando
Reply Retweet Like
Ana Vallejo retweeted
WECAN Oct 21
European organisations are having a meeting to talk about next steps in the initiatives we are running: legal , Fair Market Value, WECAN position on , among others
Reply Retweet Like
Ana Vallejo retweeted
MPE Oct 21
The CEO of , , is presenting the guiding principles developed within the initiative "Reasonable agreements between patient advocates and pharmaceutical companies", a project led by MPE in the at
Reply Retweet Like
Ana Vallejo retweeted
MPE Oct 21
"New drugs without access aren't innovation, they are just an invention. Outcomes requieres that treatment reach patients" says
Reply Retweet Like
Ana Vallejo Oct 20
Huge variations between countries in time for reimbursement decisions on new cancer drugs
Reply Retweet Like
Ana Vallejo Oct 19
Glad to see the Patient Advocacy Track full of people!
Reply Retweet Like
Ana Vallejo retweeted
MPE Oct 18
starts with a welcome session for given by
Reply Retweet Like
Ana Vallejo Oct 18
Ready to attend in Munich!
Reply Retweet Like
Ana Vallejo retweeted
MPE Oct 17
2 days left for in Munich (Germany). MPE will hold also the 2nd face to face meeting within the Advocate Development Programme with top speakers to teach our trainees how to read scientific papers, the ESMO-MCBS, or . Find us in our booth (Hall: B1, stand PA9)!
Reply Retweet Like
Ana Vallejo retweeted
MPE Oct 11
Complementary and alternative medicines are used by 1 in 2 before and during treatments, however they are frequently associated with drug-drug interactions, a estudy at ESMO 2018 report.
Reply Retweet Like
Ana Vallejo retweeted
La Vida en Rosa LVR Oct 9
, un muy Gracias a todos los profesionales que aceptan avalar nuestros artículos relacionados con la enfermedad
Reply Retweet Like
Ana Vallejo Oct 1
¿Quieres saber en qué cosiste el proyecto CARAMBA, dentro del programa , del que es miembro? Consulta este vídeo, ahora subtitulado en español.
Reply Retweet Like